Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8334
Reference
Drug alert 57/2024
Name
Drug Alert Class 4 Drug Alert 57 2024 – Class 4 medicines defect information – caution in use – Morningside Healthcare Ltd – Tramadol Hydrochloride Morningside 50mg Prolonged-Release Capsules
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Drugs
Safety
Risks
Pharmaceutical Industry
Medicines Recall
Description
Morningside Healthcare Limited has informed the MHRA of a packaging issue identified in batch MRA2303 of Tramadol Hydrochloride Morningside 50 mg Prolonged-Release Capsules and batch MRF2301 of Tramadol Hydrochloride 50 mg Capsules. There have been reports of missing capsules within sealed blister strips. Each blister strip for the affected batches should contain 10 capsules. The missing capsules in the sealed blisters has occurred due to a manufacturing issue on the packaging line. The batches in the table are the only batches believed to be impacted.
Wholesalers and Healthcare professionals are advised that there is no risk to the product’s quality or efficacy; therefore, the affected batches are not being recalled.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2024-11-27 11:19:00
Click to go back to homepage